Loading viewer...
investor_presentation
Format: PDF investor_presentation
wide-16x9W -v2 © 2021 Lam Research Corp. | 07/28/2021 1 Lam Research Corporation June Quarter 2021 Financial Results July 28, 2021
© 2021 Lam Research Corp. | 07/28/2021 1
Lam Research Corporation
June Quarter 2021 Financial Results
July 28, 2021wide-16x9W -v2
© 2021 Lam Research Corp. | 07/28/2021 2This presentation and the accompanying discussion contain “forward -looking statements” under U.S. securities
laws. Forward -looking statements include any statements that are not statements of historical fact. Examples of
forward -looking statements include, but are not limited to: (1) anticipated business, balance sheet, cash flow and
financial measures and results, including guidance, whether on a GAAP or non -GAAP basis; (2) economic, market,
industry and industry segment expectations; (3) product performance and changes in market share or customer
demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or strategies, or
otherwise deliver value for customers and stockholders; (5) the impact of the COVID -19 pandemic on our operations
and financial results, and our ability to mitigate operational and business impacts caused by it; and (6) the impact of
trade regulations, export controls and trade disputes. Forward -looking statements speak only as of the date they are
made and are subject to risks and uncertainties that could cause actual results to differ materially from those
expressed, including: the severity, magnitude and duration of the COVID –19 pandemic (and the related governmental,
public health, business and community responses to it), and their impacts on our business, results of operations and
financial condition, are evolving and are highly uncertain and unpredictable; business, political and/or regulatory
conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate
or change; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell
our products; the actions of our customers and competitors may be inconsistent with our expectations; trade
regulations, export controls, trade disputes and other geopolitical tensions may inhibit our ability to sell our products;
and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other
factors discussed in our filings with the Securities and Exchange Commission (“SEC”), including specifically the Risk
Factors described in our annual report on Form 10 –K for the fiscal year ended June 28, 2020 and our quarterly report
on Form 10 -Q for quarter ended March 28, 2021. You should not place undue reliance on forward -looking
statements. Lam undertakes no obligation to update any forward -looking statements.Cautionary Statement Regarding Forward -Looking Statements Business Review
PRESIDENT AND CHIEF EXECUTIVE OFFICERwide-16x9W -v2
© 2021 Lam Research Corp. | 07/28/2021 4
Record June Quarter & Fiscal 2021 Performance
EPS = earnings per share
Preview truncated — download the full document for the complete content.
investor_presentation
23 Pages
investor_presentation
43 Pages
Kinnate Biopharma
investor_presentation
Entergy Corporation